ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Viatris Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 778 studies whose lead sponsor is Viatris Inc. or one of 21 companies grouped under it. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 22 registry names, not the registry’s. See them and correct one ↓

Compare Viatris with Bristol-Myers Squibb and AstraZeneca →

Pipeline: 6 programs

Each counted once: 6 with a study Viatris Inc. leads registered in the last two years.

  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Viatris Inc.’s own registered studies; Viatris Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Viatris Inc.’s studies test, most open studies first — 122 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 122; every drug is on its own page, and each page lists its sponsors.

Coming up

8 of Viatris Inc.’s studies under way reach primary completion within a year, 4 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. 1J’27
  4. F
  5. 1M
  6. A
  7. 1M
  8. J
  9. 1J
  10. A
  11. S
  12. 1O
  13. 1N

Add all 8 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 778 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now91%Recruiting 5 · Enrolling by invitation 2 · Not yet recruiting 2
  • Under way, not recruiting51%
  • Completed69689%
  • Stopped early638%Terminated 50 · Withdrawn 13
  • Status unknown or other51%No longer available 4 · Status unknown 1

Phase

Where

Over the years

  1. 6507
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 726

By the year each study started; 377 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Viatris Inc.

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    434 studies →
  • Mylan Pharmaceuticals Inc
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    160 studies →
  • Mylan Inc.
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    44 studies →
  • Viatris Innovation GmbH
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies →
  • MEDA Pharma GmbH & Co. KG
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies →
  • Dey
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies →
  • Meda Pharmaceuticals
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Mylan Bertek Pharmaceuticals
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Oyster Point Pharma, Inc.
    Acquired — became part of Viatris Inc., Jan 3, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Viatris Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies
  • Viatris Specialty LLC
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Mylan Pharma UK Ltd.
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Mylan Specialty, LP
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Viatris Pharmaceuticals Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mylan Laboratories
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mylan Pharmaceuticals Private Limited
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mylan Technologies Inc.
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Viatris Korea
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Viatris Pharmaceuticals Japan Inc
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Mylan (Taiwan) Ltd
    Acquired — became part of Viatris Inc., Nov 16, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Famy Life Sciences, a Viatris Company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • BGP Products Operations GmbH, a Viatris company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Viatris Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 778. Browse all 778 →